Prestige Consumer Healthcare (PBH) Profit After Tax Growth (3y) (2013 - 2025)
Prestige Consumer Healthcare (PBH) Profit After Tax Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | 14.01% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 2.89% |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 8.71% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | -34.81% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 15.37% |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 36.74% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.38 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -70.26% |
| Sep 30, 2025 | 100.18% |
| Jun 30, 2025 | -53.93% |
| Mar 31, 2025 | -3.86% |
| Dec 31, 2024 | 6.72% |
| Sep 30, 2024 | 163.17% |
| Jun 30, 2024 | 274.40% |
| Mar 31, 2024 | -34.04% |
| Dec 31, 2023 | -13.11% |
| Sep 30, 2023 | -41.18% |
| Jun 30, 2023 | -1.22% |
| Mar 31, 2023 | -27.16% |
| Dec 31, 2022 | 145.83% |
| Sep 30, 2022 | -25.70% |
| Jun 30, 2022 | 17.93% |
| Mar 31, 2022 | 33.50% |
| Dec 31, 2021 | 199.48% |
| Sep 30, 2021 | -19.35% |
| Jun 30, 2021 | -26.64% |
| Mar 31, 2021 | 81.27% |